Companies
From start-ups to market leaders, access critical company intelligence on a global scale
- Free sign-up Sign in
-
Who We Are
-
Industries We Cover
-
Who We Serve
-
Who We Serve
Financial Institutions
Professional Services
-
-
What We Offer
-
Products & Solutions We Offer
Sector Specific
Cross-Sectors
Services
-
-
Access Free Intelligence
-
Access Free Intelligence
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
View all companies Reports
From industry deep dives to global trends, access authoritative research from our experts
View all reports Data & Insights
Uncover your next opportunity with trusted data & insights that cut across industries
View all data & insights Themes
Discover the disruptive forces shaping tomorrow's world, today
View all themes Marketplace
Explore our diverse collection of unique datasets and find the advantage you need
View all marketplace Hot Topic Reports
Get clarity into the latest emerging themes with our reports
View all trending reports - Media
- Investors
- Careers
- Contact Us
- Request a Demo
-
Microbiome Analysis
A healthy microbiome is vital because high or low microbial diversity can have different implications for health or disease, depending on the body site. Pharma is harnessing the microbiome to potentially treat auto-immune, metabolic and infectious diseases. Pipeline microbiome therapeutics show promise, but must also overcome hurdles, as it is currently unknown how the microbiome affects human health.
Our series of Microbiome Analysis reports will help you make better and more informed decisions.
Download the guide to our Microbiome Analysis report series here.
Reports in this Series
Click through our reports below to find out more, or contact us for more information on the latest reports available.
